Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate CAS 152628-01-8 Puritas >99.0% (HPLC) Telmisartan Intermedia Factory

Description:

Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate

CAS: 152628-01-8

Puritas: >99.0% (HPLC)

Aspectus: pulveris albi

Medium Telmisartanum (CAS: 144701-48-4)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate
Synonyma Telmisartan Impuritas 31;3-Methyl-4-Butyrylamido-5-Nitro Benzoic Acidum Methyl Ester;4-Butyrylamino-3-methyl-5-nitrobenzoicum Acidum Methyl Ester
CAS Number 152628-01-8
CATTUS Number RF-PI1881
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C13H16N2O5
M. Pondus 280.28
Liquescens punctum 151.0~153.0℃
Density 1.265
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba pulveris
Puritas / Analysis Methodus >99.0% (HPLC)
Damnum in Siccatio <1.00%
Residere in Ignition <0.50%
Totalis immunditias <1.00%
Metalla gravia (ut Pb) <20ppm
Test Standard Enterprise Standard
Consuetudinem Medium Telmisartanum (CAS: 144701-48-4)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate (CAS: 152628-01-8) utilis est media synthetica in productione Telmisartanae (CAS: 144701-48-4), medicamentum antihypertensivum.Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate est pars efficacioris processus synthesisendi Telmisartanae secundum immunditiam, cedem, sumptus et magnarum productionis.Telmisartan est angiotensin II receptaculum obstructorem (ARB) indicatum pro: Curatio hypertensionis, pressura sanguinis inferioris.Pressio sanguinis demissio periculum minuit eventus cardiovasculares fatales et nonfatales, imprimis ictus et infarctiones myocardiales.Periculum reductionis in inhibitores aegros ACE inhibitores cardiovasculares (CV) capere non possunt.

Epistulam tuam hic scribe et mitte nobis